Business news

    Atomo Diagnostics (ASX:AT1) leads expansion of HIV self-testing in Australia with Federal budget allocation

    Article Image

    Atomo Diagnostics heralded a major stride in HIV prevention and testing in Australia with the government's pledge to expand HIV self-testing in the latest Federal Budget.

    The $43.9 million allocation aims to bolster prevention, testing, training, and information for those at risk of HIV, aligning to eliminate HIV transmission by 2030.

    Under the initiative, free HIV self-test kits will be more accessible through a nationwide mail-out program.

    The budget will extend the South Australia-based HIV testing vending machine pilot to a national scale, ensuring testing availability across all regions.

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.

    Publisher
    Grafa